March 21, 2017 / 12:14 PM / 6 months ago

BRIEF-Invivo Therapeutics reports FDA submission

March 21 (Reuters) - Invivo Therapeutics Holdings Corp :

* Invivo Therapeutics announces submission to the FDA of its nonclinical studies module for the neuro-spinal scaffold(tm)

* Expect to receive acceptance of nonclinical module in q3 of this year

* Plan to submit manufacturing module in second half of 2017 and clinical module in 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below